Shanghai, China - The first patient implants of the Boston Scientific Corporation COGNIS™ cardiac resynchronization therapy defibrillator (CRT-D) were successfully performed in China’s Zhejiang ...
The Cardiac Resynchronization in Heart Failure (CARE-HF) [1] trial was an open-label, randomized, controlled study that evaluated the effects of cardiac resynchronization therapy (CRT) on morbidity ...
Among patients with mild heart failure, only those who have left bundle branch block (LBBB) stand to gain better long-term survival from receiving cardiac resynchronization therapy (CRT) in addition ...
The treatment of patients with heart failure is a great challenge for cardiovascular medicine and public health systems in the coming decades. In the western world the prevalence of the disease will ...
SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced that the U.S. Food and Drug Administration (FDA) ...
Upgrade to cardiac resynchronization therapy with a defibrillator (CRT-D) reduces morbidity and mortality and improves left ventricular (LV) reverse remodeling compared to an implantable ...
Results Provide Evidence Supporting Potential Expansion of Indications for CRT in Symptomatic, Permanent Atrial Fibrillation Patient Population MINNEAPOLIS & SAN FRANCISCO--(BUSINESS WIRE)-- Data ...
Receipt of a cardiac-resynchronization therapy-defibrillator (CRT-D) offers long term benefit for patients with heart failure, reduced ejection fraction, and a widened QRS complex, according to a ...
MINNEAPOLIS--(BUSINESS WIRE)-- Medtronic, Inc. (NYSE: MDT) today announced that the U.S. Food and Drug Administration’s (FDA) Circulatory Systems Devices Advisory Panel determined that the overall ...
Please provide your email address to receive an email when new articles are posted on . Long-term CRT-D use was tied to improved survival and time to adverse events vs. ICD therapy in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results